Quantbot Technologies LP Purchases 42,419 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Quantbot Technologies LP lifted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 342.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 54,822 shares of the company's stock after acquiring an additional 42,419 shares during the quarter. Quantbot Technologies LP's holdings in Henry Schein were worth $3,997,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Swedbank AB acquired a new position in shares of Henry Schein in the 1st quarter worth approximately $215,998,000. ING Groep NV bought a new position in shares of Henry Schein during the 3rd quarter worth about $63,226,000. Thompson Siegel & Walmsley LLC acquired a new stake in shares of Henry Schein in the 2nd quarter valued at about $46,683,000. Bank of Montreal Can increased its position in Henry Schein by 365.6% in the 3rd quarter. Bank of Montreal Can now owns 711,487 shares of the company's stock valued at $52,095,000 after buying an additional 558,689 shares in the last quarter. Finally, SG Americas Securities LLC raised its stake in Henry Schein by 1,622.3% during the 3rd quarter. SG Americas Securities LLC now owns 458,828 shares of the company's stock worth $33,449,000 after buying an additional 432,187 shares during the period. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Stock Up 0.5 %

Henry Schein stock traded up $0.38 during midday trading on Wednesday, hitting $77.66. 832,776 shares of the stock were exchanged, compared to its average volume of 1,400,600. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $9.68 billion, a price-to-earnings ratio of 31.80, a price-to-earnings-growth ratio of 2.20 and a beta of 0.87. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63. The business's 50-day moving average price is $71.15 and its 200-day moving average price is $69.78.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts' consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. During the same period in the previous year, the business posted $1.32 EPS. The business's revenue for the quarter was up .4% compared to the same quarter last year. On average, research analysts expect that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on HSIC shares. Evercore ISI raised their price objective on Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a research note on Tuesday, October 8th. StockNews.com upgraded shares of Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Barrington Research restated an "outperform" rating and set a $82.00 price objective on shares of Henry Schein in a report on Wednesday, November 6th. UBS Group reduced their price objective on shares of Henry Schein from $75.00 to $72.00 and set a "neutral" rating for the company in a report on Wednesday, August 7th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Henry Schein from $88.00 to $80.00 and set an "overweight" rating on the stock in a report on Monday, August 12th. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $78.89.

Insider Buying and Selling

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the company's stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares of the company's stock, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Lorelei Mcglynn sold 21,035 shares of the firm's stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares of the company's stock, valued at approximately $4,978,026.90. This trade represents a 22.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.